How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?—A prospective study

BACKGROUND: Timely stratification of Crohn's disease (CD) is essential for patients' management. The use of noninvasive accurate biomarkers is key to monitor treatment and to pursue mucosal healing, the ultimate treatment endpoint in CD. OBJECTIVE: We aimed to evaluate the performance of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Magro, Fernando, Estevinho, Maria Manuela, Catalano, Gaia, Patita, Marta, Arroja, Bruno, Lago, Paula, Rosa, Isadora, Tavares de Sousa, Helena, Ministro, Paula, Mocanu, Irina, Vieira, Ana, Castela, Joana, Moleiro, Joana, Roseira, Joana, Cancela, Eugénia, Sousa, Paula, Portela, Francisco, Correia, Luís, Moreira, Paula, Santiago, Mafalda, Dias, Sandra, Afonso, Joana, Danese, Silvio, Peyrin‐Biroulet, Laurent, Dias, Cláudia Camila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337732/
https://www.ncbi.nlm.nih.gov/pubmed/37318072
http://dx.doi.org/10.1002/ueg2.12420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337732/
https://www.ncbi.nlm.nih.gov/pubmed/37318072
http://dx.doi.org/10.1002/ueg2.12420

Ejemplares similares